ADAP
Adaptimmune Therapeutics
ADAP
ADAP
80 hedge funds and large institutions have $229M invested in Adaptimmune Therapeutics in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 24 reducing their positions, and 16 closing their positions.
Holders
80
Holders Change
-5
Holders Change %
-5.88%
% of All Funds
1.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
26
Reduced
24
Closed
16
Calls
$191K
Puts
$299K
Net Calls
-$108K
Net Calls Change
-$404K